BRPI0409309A - composições e métodos de formulação para fórmulas enterais contendo ácido siálico - Google Patents

composições e métodos de formulação para fórmulas enterais contendo ácido siálico

Info

Publication number
BRPI0409309A
BRPI0409309A BRPI0409309-7A BRPI0409309A BRPI0409309A BR PI0409309 A BRPI0409309 A BR PI0409309A BR PI0409309 A BRPI0409309 A BR PI0409309A BR PI0409309 A BRPI0409309 A BR PI0409309A
Authority
BR
Brazil
Prior art keywords
sialic acid
compositions
formulation methods
enteral formulas
containing enteral
Prior art date
Application number
BRPI0409309-7A
Other languages
English (en)
Inventor
Robert J Mcmahon
Mary Frances Locniskar
Steven Charles Rumsey
Joshua C Anthony
Ratchapong Wungtanagorn
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BRPI0409309A publication Critical patent/BRPI0409309A/pt
Publication of BRPI0409309B1 publication Critical patent/BRPI0409309B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

"COMPOSIçõES E MéTODOS DE FORMULAçãO PARA FóRMULAS ENTERAIS CONTENDO áCIDO SIáLICO". é descrita uma fórmula infantil nutricionalmente completa contendo ácido siálico derivado de um ou um número de fontes nutricionalmente apropriadas.
BRPI0409309-7A 2003-04-14 2004-03-19 Composição nutricionalmente completa e fórmula infantil BRPI0409309B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/413,508 US7867541B2 (en) 2003-04-14 2003-04-14 Compositions and methods of formulation for enteral formulas containing sialic acid
US10/413.508 2003-04-14
PCT/US2004/008451 WO2004093557A1 (en) 2003-04-14 2004-03-19 Compositions and methods of formulation for enteral formulas containing sialic acid

Publications (2)

Publication Number Publication Date
BRPI0409309A true BRPI0409309A (pt) 2006-04-18
BRPI0409309B1 BRPI0409309B1 (pt) 2020-09-15

Family

ID=33131416

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409309-7A BRPI0409309B1 (pt) 2003-04-14 2004-03-19 Composição nutricionalmente completa e fórmula infantil

Country Status (21)

Country Link
US (1) US7867541B2 (pt)
EP (1) EP1613169B1 (pt)
KR (1) KR101087332B1 (pt)
CN (1) CN100515216C (pt)
AR (1) AR043846A1 (pt)
AT (1) ATE469560T1 (pt)
BR (1) BRPI0409309B1 (pt)
CA (1) CA2522091C (pt)
CL (1) CL2004000803A1 (pt)
DE (1) DE602004027476D1 (pt)
DK (1) DK1613169T3 (pt)
EC (1) ECSP056101A (pt)
ES (1) ES2346533T3 (pt)
MX (1) MXPA05010806A (pt)
MY (1) MY154371A (pt)
NO (1) NO330441B1 (pt)
PL (1) PL1613169T3 (pt)
PT (1) PT1613169E (pt)
RU (1) RU2361408C2 (pt)
TW (1) TWI369183B (pt)
WO (1) WO2004093557A1 (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2187115T3 (es) * 1999-01-20 2003-05-16 Nutricia Nv Preparado para lactantes.
CA2431399C (fr) * 2000-12-13 2009-04-28 Institut D'optique Theorique Et Appliquee Procede de caracterisation d'une surface, et dispositif pour sa mise en oeuvre
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
CA2583704C (en) * 2004-10-12 2012-12-11 Katrina Fletcher Beta-serum dairy products, neutral lipid-depleted and/or polar lipid-enriched dairy products, and processes for their production
US20060246146A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
US20060247153A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
EP1888081B1 (en) 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions containing pufa and methods of use thereof
WO2007035870A2 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
DK1951060T3 (da) * 2005-11-04 2018-01-29 Arla Foods Amba Koncentrat afledt af et mælkeprodukt beriget med naturligt forekommende sialyllactose og en fremgangsmåde til fremstilling deraf
EP1972346B1 (en) * 2005-11-30 2015-10-14 Vegenat, S.A. Protein mixture and use thereof in the preparation of a product that is intended for oral or enteral food
EP1800675B1 (en) * 2005-12-23 2011-05-18 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
CA2706722C (en) * 2006-11-29 2016-01-12 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
US8377445B2 (en) * 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
EP2157870A1 (en) * 2007-06-25 2010-03-03 DSM IP Assets B.V. Novel prebiotics
SI2190304T1 (sl) * 2007-09-17 2012-04-30 Nutricia Nv Prehranska formulacija z visoko energijsko vsebnostjo
CN102894369B (zh) * 2007-10-19 2015-12-16 方塔拉合作集团有限公司 保持或增加成长或认知发育的方法
EP2096115A1 (en) * 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
ATE538667T1 (de) * 2008-11-10 2012-01-15 Nestec Sa Sialsäure produzierende bakterien
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
KR101158472B1 (ko) * 2009-11-05 2012-06-20 주식회사 베네비오 알코올에 유발된 간질환의 예방 또는 치료용 조성물
EP2544539B1 (en) * 2010-03-12 2015-04-29 DSM IP Assets B.V. Maternal sialic acid supplementation
EP2554057A4 (en) * 2010-03-31 2013-12-18 Vegenat S A ENERAL OR ORAL FOOD PRODUCT SPECIALLY FOR NUTRITION, PREVENTION AND MITIGATION OF NEUROLOGICAL OR NEURODEGENERATIVE ALTERATIONS OR COGNITIVE DISORDERS
WO2011121151A1 (es) * 2010-03-31 2011-10-06 Vegenat, S.A. Suplemento alimenticio funcional especialmente destinado para la nutrición, prevención y mejora en casos de alteraciones neurológicas, neurodegenerativas o trastornos cognitivos
MY196432A (en) 2010-12-31 2023-04-10 Abbott Lab Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
DK2658399T4 (da) 2010-12-31 2024-03-25 Abbott Lab Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
CA2822219C (en) 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
BR112013016903A2 (pt) 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para modular inflamação
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
PT2672844E (pt) 2011-02-10 2015-02-04 Nestec Sa Modulação do crescimento de bifidobactérias utilizando uma combinação de oligossacáridos identificados no leite humano
BR112013033565B1 (pt) 2011-06-30 2021-06-29 Chr. Hansen A/S Composição seca, pó para recém-nascido, fórmula, leite, produto alimentício ou suplemento dietético
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN103987265B (zh) 2011-08-03 2017-05-24 普罗莱克塔生物科学公司 减少细菌污染的人乳微滤
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20140179782A1 (en) * 2011-10-14 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
EP2790522B1 (en) 2011-12-14 2015-06-03 Nestec S.A. Emulsified food product containing dairy protein
US9351978B2 (en) * 2012-02-29 2016-05-31 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US20140179775A1 (en) * 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
WO2013138157A1 (en) 2012-03-14 2013-09-19 Abbott Laboratories Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
SE536599C3 (sv) * 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
EP2983517A1 (en) 2013-03-13 2016-02-17 Abbott Laboratories Infant nutritional product with rrr alpha-tocopherol
FI3821713T3 (fi) 2013-03-13 2025-03-27 Prolacta Bioscience Inc Runsasrasvaisia äidinmaitotuotteita
WO2014159967A1 (en) 2013-03-13 2014-10-02 Abbott Laboratories A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same
CN103478251B (zh) * 2013-07-23 2015-03-25 东北农业大学 一种含唾液酸婴儿配方奶粉的制备方法
CN104187742A (zh) * 2014-07-09 2014-12-10 上海育生堂科技有限公司 一种用于促进青少年儿童成长和改善大脑发育的食用组合物
MX377227B (es) 2014-09-25 2025-03-07 Soc Des Produits Nestle S A Star Sistema de formulas infantiles con niveles adaptables de oligosacaridos de la leche humana (hmo).
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US20170006897A1 (en) 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US11478011B2 (en) * 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
AU2016381834B2 (en) 2015-12-30 2021-09-23 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
CN106615146A (zh) * 2016-09-01 2017-05-10 西安银桥乳业（集团）有限公司 一种添加组合益生元的婴幼儿配方奶粉及其制备方法
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
CN107467667B (zh) * 2017-07-17 2018-06-26 北京亦贝安生物医药科技有限公司 一种含有两种不饱和脂肪酸和唾液酸的复方制剂
EP3473644A1 (en) 2017-10-17 2019-04-24 Jennewein Biotechnologie GmbH Fermentative production of n-acetylneuraminic acid
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
JP2022548785A (ja) 2019-09-24 2022-11-21 プロラクタ バイオサイエンス，インコーポレイテッド 炎症性疾患及び免疫疾患の治療のための組成物及び方法
CN111011522A (zh) * 2020-02-27 2020-04-17 青岛索康食品有限公司 一种提高免疫力的儿童配方奶粉及其制备方法
CN113068747A (zh) * 2020-03-24 2021-07-06 北京三元食品股份有限公司 一种促进孕产妇和婴幼儿健康的孕产妇配方乳粉

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
DD273543A3 (de) 1987-09-14 1989-11-22 Univ Rostock Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
DE3876986D1 (de) 1988-07-07 1993-02-04 Milupa Ag Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung.
US6020015A (en) 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
CH681543A5 (pt) * 1990-04-27 1993-04-15 Nestle Sa
JP3035833B2 (ja) 1991-01-21 2000-04-24 雪印乳業株式会社 シアル酸類含有組成物の製造方法
JP3125451B2 (ja) * 1991-11-05 2001-01-15 ソニー株式会社 信号処理方法
JPH07277929A (ja) 1994-04-01 1995-10-24 Momotani Jiyuntenkan:Kk 育毛、養毛料
US5576300A (en) 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
US5575916A (en) 1994-11-07 1996-11-19 Neose Pharmaceuticals, Inc. Method of processing a cheese processing waste stream
US5849324A (en) 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
JP2000517180A (ja) 1996-08-30 2000-12-26 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム フェニルケトン尿症患者用の栄養配合物
DE69718455T2 (de) * 1997-07-22 2003-04-30 Societe Des Produits Nestle S.A., Vevey Lipidzusammensetzung für Säuglingsnährpräparat und Herstellungsverfahren
US6168823B1 (en) 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
EP1048226B1 (en) 1999-04-29 2005-08-31 Société des Produits Nestlé S.A. Infant formula containing sweet whey protein
US6288222B1 (en) 2000-02-16 2001-09-11 Neose Technologies, Inc. Method of filtration of a dairy stream
CN1229115C (zh) 2000-02-17 2005-11-30 惠氏公司 含有益生素物质的营养配方
US6592863B2 (en) 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
GB0116509D0 (en) 2001-07-06 2001-08-29 Hannah Res Inst The Methods of extracting casein fractions from milk and caseinates and production of novel products

Also Published As

Publication number Publication date
US20040202765A1 (en) 2004-10-14
NO20055335L (no) 2006-01-03
EP1613169A1 (en) 2006-01-11
US7867541B2 (en) 2011-01-11
NO330441B1 (no) 2011-04-11
MXPA05010806A (es) 2005-12-05
MY154371A (en) 2015-06-15
ECSP056101A (es) 2006-03-01
TWI369183B (en) 2012-08-01
AR043846A1 (es) 2005-08-17
NO20055335D0 (no) 2005-11-11
TW200503631A (en) 2005-02-01
PT1613169E (pt) 2010-06-17
BRPI0409309B1 (pt) 2020-09-15
CL2004000803A1 (es) 2005-05-06
PL1613169T3 (pl) 2010-11-30
CN100515216C (zh) 2009-07-22
WO2004093557A1 (en) 2004-11-04
HK1091376A1 (zh) 2007-01-19
CN1802094A (zh) 2006-07-12
RU2361408C2 (ru) 2009-07-20
RU2005135122A (ru) 2006-03-10
ES2346533T3 (es) 2010-10-18
ATE469560T1 (de) 2010-06-15
CA2522091C (en) 2011-10-11
DK1613169T3 (da) 2010-09-20
CA2522091A1 (en) 2004-11-04
KR20060006921A (ko) 2006-01-20
EP1613169B1 (en) 2010-06-02
DE602004027476D1 (de) 2010-07-15
KR101087332B1 (ko) 2011-11-25

Similar Documents

Publication Publication Date Title
BRPI0409309A (pt) composições e métodos de formulação para fórmulas enterais contendo ácido siálico
MY162034A (en) Compositions and methods of formulation for enteral formulas containing sialic acid
EP2037739A4 (en) BENZYL-SUBSTITUTED POSITIVE ALLOSTERIC CHINOLON M1 RECEPTOR MODULATORS
BR0213612A (pt) Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
NO20055219L (no) Nye forbindelser
NO20050828L (no) lndol-3-svovelderivater
BRPI0411916A (pt) imidazoquinolinas substituìdas por sulfonamida
CL2004000590A1 (es) Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v
NO20071321L (no) Anti-inflammatoriske midler
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
DE60219911D1 (de) Pyrrolidin-2-on derivate als faktor xa inhibitoren
BR0308338A (pt) Derivados de nitrosodifenilamina e seu uso farmacêutico contra patologias de estresse oxidativo
BR9702200A (pt) Compostos bicíclicos-aromáticos composição farmacéutica composição cosmética e utilização de uma composição cosmética
BRPI0407055A (pt) Derivados de isotiazol
CY1111574T1 (el) Παραγωγα βουτανοϊκου οξεος, διαδικασιες για την παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και θεραπευτικες εφαρμογες αυτων
DK1251846T3 (da) C4-Carbonattaxaner
MXPA04003611A (es) Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
HUP0104963A2 (hu) Bőrbetegségek kezelésére szolgáló készítmények
BRPI0408848A (pt) formulações orais de cladribine
HUP0401572A2 (hu) L-karnitin alfa-ketoglutarátjai és ezeket tartalmazó gyógyászati készítmények
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
DE602005018390D1 (de) Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren
ATE425174T1 (de) Colchicosidanaloge
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MEAD JOHNSON NUTRITION COMPANY (US)

Free format text: TRANSFERIDO DE: BRISTOL-MYERS SQUIBB COMPANY

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: REF. A PETICAO NPRJ 020120045555 DE 21/05/2012.

B25A Requested transfer of rights approved

Owner name: MJN U.S HOLDING LLC (US)

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B12C Appeal against dismissal [chapter 12.3 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23C 9/20 (2006.01), A23C 9/13 (2006.01), A23L 33/

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2714 DE 10-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.